JBSS32.SA
JBSS32.SA
BRJBSSBDR002
JBS N.V. DR2
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 55/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors.

Beta (Market Relation)
-
Defensive
Volatility (5Y p.a.)
56.8% p.a.
5-Year Horizon
Max Drawdown (5Y)
-58.7%
5-Year Horizon
Sharpe Ratio
0.15
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -5%
3 Years 67.9% -39.2% 0.71 +50.6%
5 Years 56.8% -58.7% 0.15 +11.4%
10 Years 53.3% -58.7% 0.29 +17.7%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 283%.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (67.9%) is noticeably higher than the 5Y average (56.8%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (56.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -58.7% in the extended horizon.
ende